GlassScriptPhysician profile
Babak Barcohana
NPI 1659454841
$2,938,564.84
in general payments reported to CMS, 2019-2025
31 companies · $24K in 2025
The $24K reported for 2025 was more than what 80% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $14K · 2021: $9,957 · 2022: $2.6M · 2023: $210K · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $203K · Royalty Or License: $44K · Food and Beverage: $2,712 · Consulting Fee: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $203,155.25 |
| Royalty Or License | $44,159.16 |
| Food and Beverage | $2,711.96 |
| Consulting Fee | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $2,848,458.77 | 2022-2023 | Fibulink |
| Kyocera Medical Technologies, INC. | $57,507.96 | 2019-2025 | |
| Surgalign Spine Technologies, INC. | $16,761.66 | 2019-2022 | |
| Nexxt Spine LLC | $10,479.37 | 2019-2024 | Connexx Open System, Connexx Mis System, Connexx Mis & Open Systems |
| Alphatec Spine, INC | $1,122.69 | 2021 | |
| Baxter Healthcare | $513.57 | 2023-2025 | Floseal |
| Highridge Medical LLC | $436.74 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Si-Bone, INC. | $371.21 | 2019-2020 | |
| Xtant Medical INC | $354.42 | 2023-2024 | |
| Ethicon US, LLC | $336.52 | 2025 | Surgiflo Hemostatic Matrix, Stratafix, Vistaseal |
| Nevro Corp. | $284.97 | 2019-2020 | |
| Ebi, LLC | $280.19 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Spineart USA INC | $260.19 | 2025 | |
| Boston Scientific Corporation | $199.96 | 2024 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $196.29 | 2021-2023 | Intracept |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $175.50 | 2019-2022 | |
| Amgen INC. | $158.06 | 2022-2024 | Prolia, Evenity |
| Pfizer INC. | $139.83 | 2020-2021 | |
| Medacta USA, INC. | $125.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $111.80 | 2019 | |
| Renovis Surgical Technologies, INC. | $60.81 | 2019 | |
| Ibsa Pharma INC. | $46.58 | 2021-2022 | |
| Depuy Synthes Sales INC. | $46.30 | 2024 | Quickanchor Orthocord |
| Kowa Pharmaceuticals America, INC. | $26.86 | 2022 | |
| Carlsmed, INC. | $23.64 | 2022 | |
| Providence Medical Technology, INC. | $20.27 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $19.75 | 2025 | |
| Zyla Life Sciences, INC. | $15.77 | 2019 | |
| Stryker Corporation | $15.54 | 2020 | |
| Abbott Laboratories | $14.62 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,112,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Barcohana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.